<html>
<head>PUBMED IDs for OPPG</head>
<body bgcolor='#C5F0F2'><h1>OPPG</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16252235/'>Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.</a> October 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16607930/'>Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG).</a> April 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16679074/'>A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene.</a> May 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18602879/'>Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates.</a> July 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18602878/'>Glial fibrillary acidic protein promoter targets pancreatic stellate cells.</a> July 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18825883/'>Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.</a> October 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19177549/'>A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats.</a> July 7  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20096619/'>Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.</a> June 18  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20333369/'>Genetic analysis of Lrp5 function in osteoblast progenitors.</a> July 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20392224/'>Lrp5 and bone formation : A serotonin-dependent pathway.</a> May 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21407258/'>Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).</a> September 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21407247/'>Effect of walnut-enriched meat on the relationship between VCAM, ICAM, and LTB4 levels and PON-1 activity in ApoA4 360 and PON-1 allele carriers at increased cardiovascular risk.</a> December 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21997141/'>Teriparatide increases bone mineral density in a man with osteoporosis pseudoglioma.</a> March 14  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/26273492/'>A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/Î²-catenin Signaling in Humans and Mice.</a> March 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23563356/'>No mutations in the serotonin related TPH1 and HTR1B genes in patients with monogenic sclerosing bone disorders.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24225945/'>Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome.</a> June 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25384351/'>Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.</a> January 9  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25945592/'>Congenital Bilateral Retinal Detachment in Two Siblings with Osteoporosis-Pseudoglioma Syndrome.</a> April 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26048454/'>LRP receptor family member associated bone disease.</a> June 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28111184/'>LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia.</a> January 24  2017<br></body></html>
